Emerald Health Therapeutics CFO: We Are at a Great Time in Our Valuation
At the Cambridge House Extraordinary Future 2018 conference, SmallCapPower spoke with Rob Hill, CFO of Emerald Health Therapeutics, Inc. (TSXV:EMH), about the Company’s growing cultivation muscle as a Health Canada-licensed producer of cannabis. Emerald Health has a 1.1 million square foot greenhouse growing facility in British Columbia and a 75,000 square foot indoor facility in Québec. The CFO shares the Company’s long-term vision of serving both the recreational and medical cannabis markets.
To read our full disclosure, please click on the button below:
DISCLOSUREThe Content contained on this page (including any facts, views, opinions, recommendations, description of, or references to, products or securities) made available by SmallCapPower/Ubika Research is for information purposes only and is not tailored to the needs or circumstances of any particular person. Any mention of a particular security is merely a general discussion of the merits and risks as sociated there with and is not to be used or construed as an offer to sell, a solicitation of an offer to buy, or an endorsement, recommendation, or sponsorship of any entity or security by SmallCapPower/Ubika Research. The Reader should apply his/her own judgment in making any use of any Content, including, without limitation, the use of any information contained therein as the basis for any conclusions. The Reader bears responsibility for his/her own investment research and decisions. Before making any investment decision, it is strongly recommended that you seek outside advice from a qualified investment advisor. SmallCapPower/Ubika Research does not provide or guarantee any financial, legal, tax, or accounting advice or advice regarding the suitability, profitability, or potential value of any particular investment, security, or information source. Ubika and/or its affiliates and/or their respective officers, directors or employees may from time to time acquire, hold or sell securities and/or commodities and/or commodity futures contracts in certain underlying companies mentioned in this site and which may also be clients of Ubika’s affiliates. In such instances, Ubika and/or its affiliates and/or their respective officers, directors or employees will use all reasonable efforts to avoid engaging in activities that would lead to conflicts of interest and Ubika and/or its affiliates will use all reasonable efforts to comply with conflicts of interest disclosures and regulations to minimize the conflict. TAGS
- Emerald Health Therapeutics Stock Lifted by Takeover Speculationsmallcappower.comNovember 15, 2017
- Is Emerald Health Therapeutics Inc a Buy? -- The Motley Foolwww.fool.comSeptember 2, 2018
- Emerald Health Therapeutics, Inc. (EMHTF, EMH.V) Stock Profile - TNMNews.comthenationalmarijuananews.comJune 14, 2018
- Emerald Health Therapeutics buys Canadian cannabis grower for CA$90 millionmjbizdaily.comMay 4, 2018